1. Home
  2. PSNL vs CEVA Comparison

PSNL vs CEVA Comparison

Compare PSNL & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • CEVA
  • Stock Information
  • Founded
  • PSNL 2011
  • CEVA 1999
  • Country
  • PSNL United States
  • CEVA United States
  • Employees
  • PSNL N/A
  • CEVA N/A
  • Industry
  • PSNL Medical Specialities
  • CEVA Semiconductors
  • Sector
  • PSNL Health Care
  • CEVA Technology
  • Exchange
  • PSNL Nasdaq
  • CEVA Nasdaq
  • Market Cap
  • PSNL 576.8M
  • CEVA 508.9M
  • IPO Year
  • PSNL 2019
  • CEVA 2000
  • Fundamental
  • Price
  • PSNL $6.03
  • CEVA $21.86
  • Analyst Decision
  • PSNL Strong Buy
  • CEVA Strong Buy
  • Analyst Count
  • PSNL 5
  • CEVA 5
  • Target Price
  • PSNL $8.00
  • CEVA $35.60
  • AVG Volume (30 Days)
  • PSNL 993.9K
  • CEVA 256.3K
  • Earning Date
  • PSNL 08-06-2025
  • CEVA 08-06-2025
  • Dividend Yield
  • PSNL N/A
  • CEVA N/A
  • EPS Growth
  • PSNL N/A
  • CEVA N/A
  • EPS
  • PSNL N/A
  • CEVA N/A
  • Revenue
  • PSNL $85,694,000.00
  • CEVA $109,112,000.00
  • Revenue This Year
  • PSNL $0.45
  • CEVA $4.47
  • Revenue Next Year
  • PSNL $25.75
  • CEVA $16.50
  • P/E Ratio
  • PSNL N/A
  • CEVA N/A
  • Revenue Growth
  • PSNL 15.57
  • CEVA 17.04
  • 52 Week Low
  • PSNL $1.14
  • CEVA $16.02
  • 52 Week High
  • PSNL $7.20
  • CEVA $38.94
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 61.71
  • CEVA 55.51
  • Support Level
  • PSNL $6.01
  • CEVA $20.01
  • Resistance Level
  • PSNL $6.72
  • CEVA $22.63
  • Average True Range (ATR)
  • PSNL 0.43
  • CEVA 0.90
  • MACD
  • PSNL 0.01
  • CEVA 0.31
  • Stochastic Oscillator
  • PSNL 61.02
  • CEVA 72.52

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About CEVA CEVA Inc.

CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.

Share on Social Networks: